Owners, management and financials
CVR: 39371049
Previous names: Daiichi Sankyo Oncology Nordics ApS
DKK 83,558,930
Gross profit
Net result: DKK 17,269,490
Daiichi Sankyo Oncology Europe GmbH (100%)
CVR · view owners
Christophe Tiberghien
Board: 3 members
CVR · view management
Active
Founded 28 February 2018
CVR · view overview
32 employees
CVR · 2026
Director role ended: Åke Magnus Gisel
CVR · 01/02/2026
View the full event history
Daiichi Sankyo Nordics ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Daiichi Sankyo Oncology Nordics ApS. The management consists of Christophe Tiberghien. The board consists of Christophe Tiberghien, Jacob Wessel-Tolvig and Karin Margaretha Heisterberg. The company is owned by Daiichi Sankyo Oncology Europe GmbH. The company has 32 employees (2026). In 2026, the company reported a gross profit of DKK 83,558,930 and a net result of DKK 17,269,490 compared with DKK 9,020,707 the year before. Equity in the 2026 report amounted to DKK 40,346,412.
Source: annual report 2026, Danish Business Authority
Daiichi Sankyo Nordics ApS demonstrates a strong upward trajectory in profitability, with gross profit increasing from 35.6 million DKK in 2022 to 83.6 million DKK in 2026, alongside a notable rise in profit from 46,355 DKK to 17.3 million DKK in the same period. The company's equity has also significantly improved, reaching 40.3 million DKK, indicating a solid financial foundation. However, the absence of revenue figures raises concerns about transparency and overall sales performance. Positioned within the pharmaceutical wholesale industry, the company appears to be gaining strength, but continued monitoring of its revenue generation and market share will be essential for assessing long-term stability.
AI-generated summary · Generated 15/10/2026
Selskabets formål er forskning og udvikling, handel, markedsføring og distribution, import og eksport, licenssøgning samt lignende aktiviteter inden for farmaceutiske, kemiske, biokemiske, medicinske og veterinærmedicinske, biologiske, hygieniske, kosmetiske og lignende produkter og apparater, herunder medicinske hjælpemidler.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/04/2025 – 31/03/2026 | 83.6M | 17.3M | 313.2M | 40.3M | 41 | |
| 202501/04/2024 – 31/03/2025 | 69.5M | 9M | 261.5M | 23.1M | 38 | |
| 202401/04/2023 – 31/03/2024 | 57.4M | 8.4M | 181.3M | 14.1M | 26 | |
| 202301/04/2022 – 31/03/2023 | 47.8M | 2.4M | 106.7M | 5.7M | 24 | |
| 202201/04/2021 – 31/03/2022 | 35.6M | 46K | 48.9M | 3.4M | 22 | |
| 202101/04/2020 – 31/03/2021 | 27.4M | 846K | 19.8M | 3.3M | 16 | |
| 202001/04/2019 – 31/03/2020 | 20.6M | 1.2M | 10M | 2.5M | 16 | |
| 201928/02/2018 – 31/03/2019 | 2.9M | 253K | 3.9M | 1.3M | 2 |
Compared to 403 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
2 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Daiichi Sankyo Nordics ApS is 39371049.
Daiichi Sankyo Nordics ApS is owned by Daiichi Sankyo Oncology Europe GmbH.
The management of Daiichi Sankyo Nordics ApS consists of Christophe Tiberghien.
The board of Daiichi Sankyo Nordics ApS consists of Christophe Tiberghien, Jacob Wessel-Tolvig and Karin Margaretha Heisterberg.
In 2026, Daiichi Sankyo Nordics ApS reported a gross profit of DKK 83,558,930.
Daiichi Sankyo Nordics ApS had 32 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Daiichi Sankyo Nordics ApS has published its annual report for 2026. Gross profit came to DKK 83,558,930, and the net result was DKK 17,269,490.
Daiichi Sankyo Nordics ApS has won the tender "Amgros 2026 1.152.a" issued by Amgros I/S worth 167,000,000 DKK.
Contact info changed: new phone: 27219263, new email: [email protected] (February 2, 2026).
As of February 1, 2026, Christophe Tiberghien has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of February 1, 2026, Åke Magnus Gisel has left the board of directors of Daiichi Sankyo Nordics ApS.
As of February 1, 2026, Christophe Tiberghien is registered as director of Daiichi Sankyo Nordics ApS.
As of February 1, 2026, Åke Magnus Gisel has stepped down as director of Daiichi Sankyo Nordics ApS.
Daiichi Sankyo Nordics ApS has published its annual report for 2025. Gross profit came to DKK 69,481,720, and the net result was DKK 9,020,707.
Daiichi Sankyo Nordics ApS has won the tender "Amgros 2026 1.1051.a" issued by Amgros I/S worth 517,000,000 DKK.
Daiichi Sankyo Nordics ApS has published its annual report for 2024. Gross profit came to DKK 57,381,295, and the net result was DKK 8,448,867.
Daiichi Sankyo Nordics ApS has published its annual report for 2023. Gross profit came to DKK 47,832,587, and the net result was DKK 2,350,138.
As of January 19, 2023, Jacob Wessel-Tolvig has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of January 19, 2023, Stefan Gerd Koch has left the board of directors of Daiichi Sankyo Nordics ApS.
Daiichi Sankyo Nordics ApS has published its annual report for 2022. Gross profit came to DKK 35,620,722, and the net result was DKK 46,355.
As of August 3, 2022, Karin Margaretha Heisterberg has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of August 3, 2022, Tim Ellmers has left the board of directors of Daiichi Sankyo Nordics ApS.
Daiichi Sankyo Nordics ApS has published its annual report for 2021. Gross profit came to DKK 27,406,905, and the net result was DKK 846,325.
Daiichi Sankyo Nordics ApS has published its annual report for 2020. Gross profit came to DKK 20,610,270, and the net result was DKK 1,187,436.
As of August 1, 2020, Åke Magnus Gisel has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of August 1, 2020, Åke Magnus Gisel is registered as director of Daiichi Sankyo Nordics ApS.
As of July 31, 2020, Nicola Torosantucci has left the board of directors of Daiichi Sankyo Nordics ApS.
As of July 31, 2020, Nicola Torosantucci has stepped down as director of Daiichi Sankyo Nordics ApS.
As of June 1, 2020, Nicola Torosantucci has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of June 1, 2020, Nicola Torosantucci is registered as director of Daiichi Sankyo Nordics ApS.
As of May 31, 2020, Patrik Josef Mag. Grandits has left the board of directors of Daiichi Sankyo Nordics ApS.
As of May 31, 2020, Patrik Josef Grandits has stepped down as adm. dir. of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Stefan Gerd Koch has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Patrik Josef Mag. Grandits has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Stefan Gerd Koch has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Tim Ellmers has joined the board of directors of Daiichi Sankyo Nordics ApS.
As of September 11, 2019, Stefan Gerd Koch has left the board of directors of Daiichi Sankyo Nordics ApS.
On September 11, 2019, the company changed its name from Daiichi Sankyo Oncology Nordics ApS to Daiichi Sankyo Nordics ApS.
Daiichi Sankyo Nordics ApS has published its annual report for 2019. Gross profit came to DKK 2,876,751, and the net result was DKK 253,181.
As of February 28, 2018, KPMG P/S has been appointed auditor of Daiichi Sankyo Nordics ApS.
As of February 28, 2018, Patrik Josef Grandits is registered as adm. dir. of Daiichi Sankyo Nordics ApS.
As of February 28, 2018, is registered as an owner of Daiichi Sankyo Nordics ApS with an ownership share of 100%.
Daiichi Sankyo Nordics ApS was founded on February 28, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 33671245
CVR 40041796
CVR 45346951
CVR 19389006
CVR 39359340
